Belgium Reports First Infection with New WHO)”>Monkeypox Variant
Belgian health authorities announced the country’s first case of monkeypox infection, a variant new to Europe. The patient, who recently traveled to Nigeria, is receiving treatment in an Infectious Diseases Unit, posing no public health risk, according to the Scientific Institute of Public Health (WGS).
"We are monitoring the situation closely," said a WGS spokesperson. "Although the new variant behaves similarly to previously known strains, continuous evaluation is crucial for effective control and prevention measures."
The new variant, named Clade III, differs genetically from the Clade I and II strains previously circulating in Europe and Africa. Initial analyses suggest it shares some similarities with the Clade III strain prevalent in West and Central Africa.
The World Health Organization (WHO) has been informed about the case, and Belgian authorities are coordinating with international counterparts to assess any potential public health implications. Global efforts are ongoing to understand the full extent and impact of this new variant.
While no immediate changes to monkeypox containment strategies are recommended, health officials urge vigilance and preparedness. Anyone experiencing symptoms associated with monkeypox—such as fever, severe headaches, lymphadenopathy, back pain, myalgia, and skin rash—should seek medical attention and inform healthcare professionals of their travel history.
As research continues, more information about this new variant will provide insights into its transmission, impact, and potential vaccine or treatment requirements. Until then, following established infection prevention and control measures remains essential to ensure the safety and health of all individuals.
